Sm 153
1.93 d
β- 0.7, 0.8...
γ 103, 70...

Chemical properties

Sm-153 is a radiolanthanide, usually in trivalent state. It can be radiolabelled with macrocyclic chelators, in particular DOTA. The ionic radius is 95.8 pm.

Nuclear properties

Sm-153 decays by β- decay with a half-life of 1.9285(2) days to stable Eu-153. It emits a low to medium energy β- spectrum with 225 keV average energy and 808 keV maximum energy. In addition to β- emission it shows ample emission of low energy conversion and Auger electrons REF, thus emitting in total about 2.34 electrons (with energies above 4 keV) per decay.

Moreover, Sm-153 emits γ-rays at 103 keV (29.14%) suitable for SPECT imaging.

The mean electron energy emitted per decay is 265 keV, the mean photon energy per decay is 62 keV REF.

Production

Sm-153 is produced by thermal neutron bombardment of enriched Sm-152 oxide targets in the BR2 reactor at SCK CEN or the MARIA reactor at NCBJ. The produced carrier-added Sm-153 is then mass separated at the CERN MEDICIS facility to obtain n.c.a. Sm-153 with high molar activity REF.

Distribution

Radionuclides will be shipped from CERN MEDICIS in solid form, implanted into NaCl, Al or Zn layer on a metallic foil.

Examples of use

  • c.a. Sm-153 with limited specific activity is mainly used for bone pain palliation, commercially available under the brand name Quadramet®.
  • The high-specific activity variant described here enables applications for receptor-targeted radionuclide therapy.
  • Sm-153 is also suited as source for Mößbauer spectroscopy REF, a highly sensitive technique to characterize the chemical state and chemical environment of samarium bound in solids or frozen ex vivo samples.

Purity grades available

research/preclinical

No carrier added (n.c.a.)

Yes
ParameterSpecifications
Production routeSm-152(n,γ)Sm-153 + mass separation
DaughterDecays to stable Eu-153: 100% β-
Half-life1.93 d
ProcessingOff-line mass separation + 3-step column separation
Primary Container20 mL borosilicate glass vial with Al foil screw cap (solid samples) from MEDICIS
Product GradeAvailable in n.c.a. form (but not in theoretical specific activity)
Physical FormSolid
Chemical FormAtoms/elements implanted in solid foil
Radioactive Concentration (gamma spectrometry)> 50 MBq/ml
AppearanceClear colourless solution
Radionuclide identification (gamma spectrometry)70 keV, 97 keV and 103 keV gamma lines present
Radionuclidic Purity (gamma spectrometry)>99.99%
Chemical purity (ICP-OES)n.a.
Molar activity (ICP-OES)280 GBq/μmol Sm at time of mass separation (>11% of theoretical maximum)
Apparent Molar ActivityLabelling up to 50 MBq/nmol p-SCN-Bn-DOTA and DOTATE
Microbiological qualityn.a.
Bacterial endotoxinn.a.
pH (pH strips)1-2
Additional information
Activity availableUp to 1500 MBq at the end of mass separation. On demand (availability CERN-MEDICIS + reactor cycle)
Activity limit for UN2910 (excepted package) shipment0.6 GBq in dry state or 60 MBq in liquid form
Other informationLabelling up to 50 MBq/nmol p-SCN-Bn-DOTA and DOTATATE

Applications

  • β-therapy
  • SPECT

Point of supply

  • Geneva, Switzerland/France

Involved production facilities

SCK CEN, Belgium
NCBJ, Poland
CERN, International

Involved biomedical facilities

To find out in which biomedical facilities you can use this radionuclide, contact the helpdesk.

Helpdesk